GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

Pakistan · Delayed Price · Currency is PKR

320.08

-9.85 (-2.99%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	61.19B	49.66B	41.84B	36.66B	35.09B
Pharmaceuticals Growth	23.21%	18.69%	14.13%	4.48%	-4.08%
Total	61.19B	49.66B	41.84B	36.66B	35.09B
Total Growth	23.21%	18.69%	14.13%	4.48%	-4.08%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Unallocated Sales Tax	-628.93M	-496.75M	-	-	-
Unallocated Commissions, Returns and Discounts	-417.03M	-1.58B	-	-	-
Pakistan	62.22B	51.74B	44.27B	38.12B	36.40B
Pakistan Growth	20.25%	16.88%	16.14%	4.72%	-3.27%
Export	15.86M	-	26.47M	28.88M	16.90M
Export Growth	-	-	-8.36%	70.93%	-70.73%
Unallocated	-	-	-2.45B	-1.49B	-1.33B
Total	61.19B	49.66B	41.84B	36.66B	35.09B
Total Growth	23.21%	18.69%	14.13%	4.48%	-4.08%

Source: S&P Global Market Intelligence.